WallStreetZenWallStreetZen

NASDAQ: ANGO
Angiodynamics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Angiodynamics earnings were -$34.0M for the trailing 12 months ending May 31, 2025, with N/A growth year over year. The latest ANGO earnings report on May 31, 2025 announced Q2 2025 earnings of -$6.1M, up 37.3% from last quarter. For the last reported fiscal year 2025 ending May 31, 2025, ANGO reported annual earnings of -$34.0M, with -81.6% growth. The next ANGO earnings date is Oct 1, 2025.

ANGO earnings history

Current Revenue
$292.5M
Current Earnings
-$34.0M
Current Profit Margin
-11.6%

ANGO Return on Equity

Current Company
-18.1%
Current Industry
14.3%
Current Market
34.5%
ANGO's Return on Equity (-18.1%)... subscribe to Premium to read more.
High Return on Equity Performance

ANGO undefined

Current Company
-11.8%
Current Industry
12.1%
ANGO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ANGO announces earnings.

ANGO undefined

Current Company
-17.17%
Current Industry
14.7%
ANGO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ANGO vs Medical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ANGO-$7.25M-$33.99MN/A-$0.83
NYXH-$62.58M-$78.33MN/A-$2.23
OSUR-$19.64M-$31.96MN/A-$0.42
SMTI-$1.59M-$11.43MN/A-$1.34
STXS-$24.15M-$26.65MN/A-$0.31
View Top Medical Stocks

ANGO earnings dates

Next earnings date
Oct 1, 2025

Angiodynamics Earnings Reports & History FAQ

What were Angiodynamics's earnings last quarter?

On ANGO's earnings call on Invalid Date, Angiodynamics (NASDAQ: ANGO) reported Q2 2025 earnings per share (EPS) of -$0.15, up 54.55% year over year. Total ANGO earnings for the quarter were -$6.05 million. In the same quarter last year, Angiodynamics's earnings per share (EPS) was -$0.33.

If you're new to stock investing, here's how to buy Angiodynamics stock.

When does Angiodynamics report earnings?

The next ANGO earnings call is Invalid Date. Add ANGO to your watchlist to be reminded of Angiodynamics's next earnings date.

Is Angiodynamics profitable or losing money?

As of the last Angiodynamics earnings report, Angiodynamics is currently losing money. Angiodynamics's net profit (also called net income) for the twelve months ending May 31, 2025 was -$33.99 million, a 81.56% decrease year over year.

What was ANGO's earnings growth in the past year?

As of Angiodynamics's earnings date in Invalid Date, Angiodynamics's earnings has grown year over year. ANGO earnings in the past year totalled -$33.99 million.

What are Angiodynamics's earnings expectations?

The current EPS estimate for Angiodynamics's earnings report in Invalid Date is -$0.08.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.